Article
MTHFR genotype and differential evolution of metabolic parameters after initiation of a second generation antipsychotic: an observational study.
International clinical psychopharmacology - 1 Sept 2010
van Winkel Ruud, Moons Tim, Peerbooms Odette, Rutten Bart, Peuskens Joseph, Claes Stephan, van Os Jim, De Hert Marc
Abstract excerpt
Most second-generation antipsychotics (SGAs) induce metabolic disturbances, but large differences exist in the degree to which individual patients develop these. Little is known about genetic factors associated with differential liability. Cross-sectional studies suggested an association between polymorphisms in 5,10-methylenetetraydrofolate reductase (MTHFR) and metabolic syndrome in patients with schizophrenia....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
